Nancy Sullivan
16Patents
4h-index
26Co-inventors
56Inventor score
Filing activity: Sep 24, 2002 → Jul 30, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8106026B2 | Development of a preventive vaccine for filovirus infection in primates | Chemistry; Metallurgy | 10 | Active |
| US8101739B2 | Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector | Chemistry; Metallurgy | 8 | Active |
| US9526777B2 | Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein | Chemistry; Metallurgy | 6 | Active |
| US9012618B2 | Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures | Chemistry; Metallurgy | 4 | Active |
| US7635688B2 | Development of a preventive vaccine for filovirus infection in primates | Chemistry; Metallurgy | 3 | Expired |
| US8106027B2 | Development of a preventive vaccine for filovirus infection in primates | Chemistry; Metallurgy | 2 | Active |
| US8124592B2 | Development of a preventive vaccine for filovirus infection in primates | Chemistry; Metallurgy | 2 | Active |
| US7635485B2 | Method of accelerated vaccination against Ebola viruses | Emerging Cross-Sectional Technologies | 1 | Expired |
| US10160795B2 | Neutralizing antibodies to Ebola virus glycoprotein and their use | Physics | 1 | Active |
| US8017130B2 | Method of accelerated vaccination against Ebola viruses | Emerging Cross-Sectional Technologies | 1 | Active |
| US11976109B2 | Neutralizing antibodies to ebola virus glycoprotein and their use | Physics | 0 | Active |
| US8080974B2 | Battery charge indicator | Emerging Cross-Sectional Technologies | 0 | Active |
| US9701718B2 | Adenovirus serotype 26 and serotype 35 filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US10584355B2 | Chimpanzee adenoviral vector-based filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US11913013B2 | Chimpanzee adenoviral vector-based filovirus vaccines | Chemistry; Metallurgy | 0 | Active |
| US10273288B2 | Neutralizing antibodies to Ebola virus glycoprotein and their use | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.